v3.26.3
Basis of Financial Statements (Tables)
9 Months Ended
Sep. 30, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Class of Treasury Stock The following summarizes the repurchases for the nine months ended September 30, 2026, pursuant to the Repurchase Programs.
Nine months ended September 30, 2026
Total number of shares purchased (in millions)4.52 
Average price paid per share$26.44 
Total cost of shares purchased (in millions)$120 
Schedule of Changes in Balance of Other Comprehensive Income (Loss)
Changes in the balance of OCI for the three and nine months ended September 30, 2026 and 2025 by component are as follows (in millions).
Three months ended September 30, 2026
Unrealized gain (loss) on investments and other financial instruments, net (excluding investments in unconsolidated affiliates)Change in current discount rate- future policy benefitsChange in instrument-specific credit risk - market risk benefitsForeign currency translation and other (a)Total accumulated other comprehensive income (loss)
Balance at June 30, 2026$(2,271)$716 $(92)$(11)$(1,658)
Reclassification adjustments included in net earnings (b)32 — — — 32 
Other comprehensive income (loss) before tax, net of reclassifications(1,837)612 21 (11)(1,215)
Deferred income tax (expense) benefit366 (128)(4)2 236 
Balance at September 30, 2026$(3,710)$1,200 $(75)$(20)$(2,605)
Three months ended September 30, 2025
Unrealized gain (loss) on investments and other financial instruments, net (excluding investments in unconsolidated affiliates)Change in current discount rate- future policy benefitsChange in instrument-specific credit risk - market risk benefitsForeign currency translation and other (a)Total accumulated other comprehensive income (loss)
Balance at June 30, 2025$(2,261)$666 $(83)$8 $(1,670)
Reclassification adjustments included in net earnings (b)10 — — — 10 
Other comprehensive income (loss) before tax, net of reclassifications548 (162)(32)1 355 
Deferred income tax (expense) benefit(111)34 6 — (71)
Balance at September 30, 2025$(1,814)$538 $(109)$9 $(1,376)
(a)Other includes changes in hedging instruments.
(b)Net of income tax (expense) benefit of $(8) million and an immaterial amount for the three months ended September 30, 2026 and 2025, respectively.
Nine months ended September 30, 2026
Unrealized gain (loss) on investments and other financial instruments, net (excluding investments in unconsolidated affiliates)Change in current discount rate- future policy benefitsChange in instrument-specific credit risk - market risk benefitsForeign currency translation and other (a)Total accumulated other comprehensive income (loss)
Balance at December 31, 2025$(1,951)$563 $(102)$2 $(1,488)
Reclassification adjustments included in net earnings (b)163 — — — — 163 
Other comprehensive income (loss) before tax, net of reclassifications(2,406)806 34 (28)(1,594)
Deferred income tax (expense) benefit484 (169)(7)6 314 
Balance at September 30, 2026$(3,710)$1,200 $(75)$(20)$(2,605)
Nine months ended September 30, 2025
Unrealized gain (loss) on investments and other financial instruments, net (excluding investments in unconsolidated affiliates)Change in current discount rate- future policy benefitsChange in instrument-specific credit risk - market risk benefitsForeign currency translation and other (a)Total accumulated other comprehensive income (loss)
Balance at December 31, 2024$(2,637)$798 $(78)$(6)$(1,923)
Reclassification adjustments included in net earnings (b)10 — — (1)9 
Other comprehensive income (loss) before tax, net of reclassifications1,020 (329)(39)20 672 
Deferred income tax (expense) benefit(207)69 8 (4)(134)
Balance at September 30, 2025$(1,814)$538 $(109)$9 $(1,376)
(a)Other includes changes in hedging instruments.
(b)Net of income tax (expense) benefit of $(43) million and an immaterial amount for the nine months ended September 30, 2026 and 2025, respectively.